|
Curtis and thread, Hermant Shah, respected independent drug analyst at HKS & Co., was interviewed at the weekend Squawk Box program of CNBC. He considered the pharmaceutical sector to be overvalued, and the biotech stocks as well, for that matter. Drug stocks he'll recommend buying now are WLA and MTC, as cheaper ways to play PFE (buying those two similar to buying PFE's marketing savvy). Said that if AHP was willing to pay some $60 for MTC, then the stock would be worth $60 to someone else; also that MTC has the lowest margin in the business, thus potentially more upside if the co. improves its efficiencies, or else it would be taken over if it continues in its old path. In essence, he said what we've all discussed previously in this thread. |
